Other news to note
TNI Biotech Inc., of Orlando, Fla., said it obtained approval from the Government of Malawi's drug regulatory authority, the Malawi Pharmacy, Medicines and Poisons Board, for the marketing and sale of low-dose naltrexone in Malawi for the treatment of patients with cancer. TNI said it intends to seek approval for sale in additional emerging nations.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter